Imagine building a better healthcare journey for patients with cancer, where individuals and their loved ones feel seen, supported, and heard by their care team – both in and out of the clinic. Where fast access to high-quality care is the norm, not the exception.
Actuary - US
United States
October 28, 2026
Job description
The role
Working directly with the founders and the autonomous AI actuary, you will lead the business growth and the delivery of actuarial studies in the US.
Specifically, you will:
- Review and sign actuarial studies - feasibility studies, statements of actuarial opinions, ratings plans and more. Your expert actuarial feedback will be used to continuously improve the autonomous AI actuary
- Manage client relationships - become a trusted advisor to our US clients and help them understand how actuarial results impact their business
- Grow the US business - own the commercial pipeline from origination to signature
˜
Requirements
• High agency and ownership mentality
• Tasteful and able to judge independently from consensus or AI slop
• Qualified to sign statements of actuarial opinion (FCAS or FSA, MAAA
• Based in San Francisco, or remote / hybrid elsewhere in the US, with regular travel to meet clients and attend industry events
˜
Nice to have
• Academic excellence
• 3 – 10 years of actuarial experience, mostly in P&C, in consulting or at a risk carrier
• Experience with captives or risk retention groups
• Demonstrated track-record in client-facing positions
• Demonstrated track-record using AI tools
Apply now
Opens workatastartup.com in a new tab. If they ask how you found the role, mention RemoWork.
We exist to create a more connected, compassionate, and confident experience for people with cancer and those who care for them. We make it easier to get answers, access high-quality care quickly, and feel supported throughout treatment and beyond.
Ethos (Nasdaq: $LIFE) is a leading life insurance technology company on a mission to protect families by democratizing access to life insurance and empowering agents at scale.